See more : Biocept, Inc. (BIOCQ) Income Statement Analysis – Financial Results
Complete financial analysis of Solon Eiendom ASA (SOLON.OL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Solon Eiendom ASA, a leading company in the Real Estate – Development industry within the Real Estate sector.
You may be interested
- Swiss Re AG (SSREF) Income Statement Analysis – Financial Results
- First Community Corporation PFD SER A (FCCTP) Income Statement Analysis – Financial Results
- Nam Tai Property Inc. (NTP) Income Statement Analysis – Financial Results
- Fonciere Inea S.A. (INEA.PA) Income Statement Analysis – Financial Results
- Hallador Energy Company (HNRG) Income Statement Analysis – Financial Results
Solon Eiendom ASA (SOLON.OL)
About Solon Eiendom ASA
Solon Eiendom ASA acquires, develops, and sells residential real estate properties in Norway. The company was formerly known as Bionor Pharma ASA and changed its name to Solon Eiendom ASA. The company was founded in 2006 and is based in Oslo, Norway. Solon Eiendom ASA is a subsidiary of Samhällsbyggnadsbolaget i Norden AB (publ). As on January 20, 2022, Solon Eiendom ASA was taken private.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.50B | 1.58B | 924.05M | 878.02M | 691.50M | 85.00K | 1.77M | 4.20M | 4.22M | 109.50M | 12.59M | 20.67M | 98.44M | 68.97M | 82.84M | 25.35M | 4.98M | 11.00M | 51.26M | 15.87M |
| Cost of Revenue | 1.15B | 1.21B | 647.71M | 704.90M | 558.67M | 0.00 | 1.22M | 1.71M | 1.86M | 1.61M | 762.00K | 9.30M | 15.37M | 7.28M | 7.88M | 504.00K | 0.00 | 0.00 | 24.41M | 0.00 |
| Gross Profit | 351.70M | 379.26M | 276.35M | 173.12M | 132.83M | 85.00K | 544.00K | 2.49M | 2.36M | 107.89M | 11.83M | 11.37M | 83.07M | 61.69M | 74.95M | 24.84M | 4.98M | 11.00M | 26.85M | 15.87M |
| Gross Profit Ratio | 23.47% | 23.93% | 29.91% | 19.72% | 19.21% | 100.00% | 30.80% | 59.38% | 55.87% | 98.53% | 93.95% | 55.00% | 84.39% | 89.45% | 90.48% | 98.01% | 100.00% | 100.00% | 52.38% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.14M | 0.00 | 0.00 | 19.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 28.48M | 7.33M | 5.83M | 4.76M | 1.73M | 36.64M | 0.00 | 0.00 | 11.56M | 0.00 | 0.00 | 0.00 | 0.00 | -31.85M | -42.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 87.00K | 0.00 | 0.00 | 0.00 | 0.00 | 43.07M | 55.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.48M | 7.33M | 5.83M | 4.76M | 1.73M | 36.64M | 0.00 | 0.00 | 11.65M | 0.00 | 0.00 | 0.00 | 0.00 | 11.23M | 13.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 185.53M | 116.67M | 71.64M | 59.64M | 32.52M | 37.75M | 70.02M | 89.81M | 41.17M | 61.84M | 56.30M | 9.05M | 86.59M | 67.29M | 73.66M | 34.58M | 15.70M | 27.23M | 106.24M | 174.83M |
| Operating Expenses | 214.01M | 124.00M | 77.48M | 64.40M | 34.25M | 97.54M | 70.02M | 89.81M | 72.04M | 61.84M | 56.30M | 9.05M | 86.59M | 78.52M | 86.90M | 34.58M | 15.70M | 27.23M | 106.24M | 174.83M |
| Cost & Expenses | 1.36B | 1.33B | 725.18M | 769.30M | 592.92M | 97.54M | 71.24M | 91.51M | 73.90M | 63.44M | 57.06M | 18.35M | 101.96M | 85.80M | 94.79M | 35.09M | 15.70M | 27.23M | 130.65M | 174.83M |
| Interest Income | 2.00M | 15.75M | 1.53M | 897.00K | 191.00K | 762.00K | 1.60M | 2.46M | 4.02M | 5.14M | 1.66M | 0.00 | 5.04M | 41.00K | 10.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 40.64M | 44.44M | 13.80M | 6.70M | 32.92M | 173.00K | 41.00K | 253.00K | 1.10M | 2.18M | 4.64M | 0.00 | 2.21M | 734.00K | 560.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 9.49M | 4.91M | 4.09M | 1.68M | 629.00K | 11.29M | 11.18M | 11.52M | 11.46M | 11.30M | 9.22M | 353.00K | 3.81M | 21.33M | 9.07M | 2.55M | 3.18M | 11.82M | 8.49M | 5.44M |
| EBITDA | 121.35M | 230.05M | 198.27M | -37.29M | 65.81M | -85.27M | -56.84M | -73.66M | -54.21M | 62.50M | -33.58M | 5.67M | 5.32M | -8.24M | -1.67M | -7.06M | -7.55M | 1.30M | -58.10M | -127.48M |
| EBITDA Ratio | 8.10% | 14.52% | 21.46% | -4.25% | 9.52% | -100,312.94% | -3,218.46% | -1,753.74% | -1,283.33% | 57.07% | -266.73% | 27.41% | 5.41% | -11.95% | -2.01% | -27.86% | -151.38% | 11.84% | -113.33% | -803.06% |
| Operating Income | 137.69M | 255.26M | 198.87M | 108.72M | 98.57M | -97.45M | -69.48M | -87.31M | -69.68M | 46.06M | -44.47M | 2.32M | -3.52M | -16.83M | -11.95M | -9.74M | -10.71M | -16.23M | -79.39M | -158.96M |
| Operating Income Ratio | 9.19% | 16.11% | 21.52% | 12.38% | 14.26% | -114,650.59% | -3,934.09% | -2,078.83% | -1,649.60% | 42.06% | -353.20% | 11.23% | -3.58% | -24.40% | -14.43% | -38.44% | -214.93% | -147.52% | -154.87% | -1,001.38% |
| Total Other Income/Expenses | -60.92M | -57.60M | -21.24M | -13.59M | -61.46M | 727.00K | 1.42M | 1.88M | 2.92M | 2.96M | -2.98M | 8.00K | 2.82M | -13.47M | 652.00K | 0.00 | -15.00K | 5.71M | 12.81M | 26.04M |
| Income Before Tax | 76.77M | 197.66M | 177.63M | 95.13M | 37.12M | -96.73M | -68.05M | -85.43M | -66.76M | 49.02M | -47.45M | 2.33M | -699.00K | -30.30M | -11.30M | 0.00 | -10.73M | -10.52M | -66.59M | -132.92M |
| Income Before Tax Ratio | 5.12% | 12.47% | 19.22% | 10.83% | 5.37% | -113,795.29% | -3,853.57% | -2,034.14% | -1,580.59% | 44.77% | -376.87% | 11.27% | -0.71% | -43.93% | -13.64% | 0.00% | -215.23% | -95.65% | -129.89% | -837.32% |
| Income Tax Expense | -19.15M | 44.62M | 43.76M | 21.05M | 9.94M | 900.00K | 1.46M | 2.13M | 4.01M | 5.14M | 3.00K | 8.00K | 5.04M | -12.74M | 1.21M | 0.00 | -15.00K | 5.71M | 12.81M | 233.00K |
| Net Income | 90.37M | 136.08M | 136.62M | -66.72M | 22.33M | -96.73M | -68.05M | -85.43M | -66.76M | 49.02M | -47.46M | 5.31M | -699.00K | -30.30M | -11.30M | -9.61M | -10.73M | -10.52M | -66.59M | -133.15M |
| Net Income Ratio | 6.03% | 8.59% | 14.79% | -7.60% | 3.23% | -113,795.29% | -3,853.57% | -2,034.14% | -1,580.59% | 44.77% | -376.90% | 25.70% | -0.71% | -43.93% | -13.64% | -37.92% | -215.23% | -95.65% | -129.89% | -838.79% |
| EPS | 1.23 | 2.05 | 2.46 | -1.38 | 0.66 | -35.51 | -26.68 | -37.92 | -31.95 | 24.73 | -25.68 | 5.19 | -0.68 | -30.53 | -12.26 | -11.20 | -12.62 | -12.37 | -78.32 | -149.47 |
| EPS Diluted | 1.23 | 2.05 | 2.46 | -1.38 | 0.65 | -35.51 | -26.68 | -37.92 | -31.95 | 24.73 | -25.68 | 5.19 | -0.68 | -30.53 | -12.26 | -11.20 | -12.62 | -12.37 | -78.32 | -149.47 |
| Weighted Avg Shares Out | 73.31M | 66.40M | 55.61M | 48.48M | 33.97M | 2.72M | 2.55M | 2.25M | 2.09M | 1.98M | 1.85M | 1.02M | 1.02M | 992.65K | 921.73K | 858.15K | 850.17K | 850.17K | 850.17K | 890.79K |
| Weighted Avg Shares Out (Dil) | 73.31M | 66.40M | 55.61M | 48.48M | 34.13M | 2.72M | 2.55M | 2.25M | 2.09M | 1.98M | 1.85M | 1.02M | 1.02M | 992.65K | 921.73K | 858.15K | 850.17K | 850.17K | 850.17K | 890.79K |
No news found for: SOLON.OL
Source: https://incomestatements.info
Category: Stock Reports